Back to Search Start Over

C9orf72 poly(GR) aggregation induces TDP-43 proteinopathy.

Authors :
Cook CN
Wu Y
Odeh HM
Gendron TF
Jansen-West K
Del Rosso G
Yue M
Jiang P
Gomes E
Tong J
Daughrity LM
Avendano NM
Castanedes-Casey M
Shao W
Oskarsson B
Tomassy GS
McCampbell A
Rigo F
Dickson DW
Shorter J
Zhang YJ
Petrucelli L
Source :
Science translational medicine [Sci Transl Med] 2020 Sep 02; Vol. 12 (559).
Publication Year :
2020

Abstract

TAR DNA-binding protein 43 (TDP-43) inclusions are a pathological hallmark of frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS), including cases caused by G <subscript>4</subscript> C <subscript>2</subscript> repeat expansions in the C9orf72 gene (c9FTD/ALS). Providing mechanistic insight into the link between C9orf72 mutations and TDP-43 pathology, we demonstrated that a glycine-arginine repeat protein [poly(GR)] translated from expanded G <subscript>4</subscript> C <subscript>2</subscript> repeats was sufficient to promote aggregation of endogenous TDP-43. In particular, toxic poly(GR) proteins mediated sequestration of full-length TDP-43 in an RNA-independent manner to induce cytoplasmic TDP-43 inclusion formation. Moreover, in GFP-(GR) <subscript>200</subscript> mice, poly(GR) caused the mislocalization of nucleocytoplasmic transport factors and nuclear pore complex proteins. These mislocalization events resulted in the aberrant accumulation of endogenous TDP-43 in the cytoplasm where it co-aggregated with poly(GR). Last, we demonstrated that treating G <subscript>4</subscript> C <subscript>2</subscript> repeat-expressing mice with repeat-targeting antisense oligonucleotides lowered poly(GR) burden, which was accompanied by reduced TDP-43 pathology and neurodegeneration, including lowering of plasma neurofilament light (NFL) concentration. These results contribute to clarification of the mechanism by which poly(GR) drives TDP-43 proteinopathy, confirm that G <subscript>4</subscript> C <subscript>2</subscript> -targeted therapeutics reduce TDP-43 pathology in vivo, and demonstrate that alterations in plasma NFL provide insight into the therapeutic efficacy of disease-modifying treatments.<br /> (Copyright © 2020 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works.)

Details

Language :
English
ISSN :
1946-6242
Volume :
12
Issue :
559
Database :
MEDLINE
Journal :
Science translational medicine
Publication Type :
Academic Journal
Accession number :
32878979
Full Text :
https://doi.org/10.1126/scitranslmed.abb3774